Change In Working Capital - Diffusion Pharmaceuticals Inc (NASDAQ:CRVO) - Alpha Spread
D

Diffusion Pharmaceuticals Inc
NASDAQ:CRVO

Watchlist Manager
Diffusion Pharmaceuticals Inc
NASDAQ:CRVO
Watchlist
Price: 17.47 USD 10.57% Market Closed
Market Cap: 144.2m USD
Have any thoughts about
Diffusion Pharmaceuticals Inc?
Write Note

Diffusion Pharmaceuticals Inc
Change in Working Capital

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Diffusion Pharmaceuticals Inc
Change in Working Capital Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Change in Working Capital Analysis
Latest Figures & CAGR of Competitors

Company Change in Working Capital CAGR 3Y CAGR 5Y CAGR 10Y
D
Diffusion Pharmaceuticals Inc
NASDAQ:CRVO
Change in Working Capital
$2m
CAGR 3-Years
16%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Change in Working Capital
-$49m
CAGR 3-Years
70%
CAGR 5-Years
49%
CAGR 10-Years
5%
Gilead Sciences Inc
NASDAQ:GILD
Change in Working Capital
-$4.1B
CAGR 3-Years
-20%
CAGR 5-Years
-28%
CAGR 10-Years
-13%
Amgen Inc
NASDAQ:AMGN
Change in Working Capital
-$1.4B
CAGR 3-Years
-10%
CAGR 5-Years
-26%
CAGR 10-Years
N/A
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Change in Working Capital
-$762.1m
CAGR 3-Years
-28%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Change in Working Capital
-$721.7m
CAGR 3-Years
45%
CAGR 5-Years
-15%
CAGR 10-Years
N/A

See Also

What is Diffusion Pharmaceuticals Inc's Change in Working Capital?
Change in Working Capital
2m USD

Based on the financial report for Jun 30, 2024, Diffusion Pharmaceuticals Inc's Change in Working Capital amounts to 2m USD.

What is Diffusion Pharmaceuticals Inc's Change in Working Capital growth rate?
Change in Working Capital CAGR 3Y
16%

The average annual Change in Working Capital growth rates for Diffusion Pharmaceuticals Inc have been 16% over the past three years .

Back to Top